ABSTRACT
INTRODUCTION
. In contrast the recent study of Bixler, et al., (2011) [9] , showed that chronic insulin treatment of diabetes does not fully normalize alterations in the retinal transcriptome. Moreover, the ultimate complication for diabetic patients, particularly in IDDM patients is hyperlipidemia with coronary heart diseases that are ameliorated by insulin treatment [1] . The therapy of diabetes began with the use of pancreatic extract of beef to lower blood glucose level in pancreatomized dogs, nowadays; several preps of bovine and human insulin are available for therapy of IDDM. Although bovine and porcine insulin are similar to human insulin, their composition is slightly different. Consequently, a number of patients' immune systems produce antibodies against it, neutralizing its actions and resulting in inflammatory responses at injection sit, were fears of long term complications ensuing from the regular injection of a foreign substance, as well as a projected decline in the production of animal derived insulin. These factors led researchers to consider synthesizing Humulin by inserting the insulin gene into a suitable vector, the E. coli bacterial cell, to produce insulin that is chemically identical to its naturally produced counterpart. This has been achieved using Recombinant DNA technology [10] . Human insulin is supplied in a variety of forms in solution or suspension for injection, crystalline insulin may be prepared for therapeutic use by making solution either of acidic or neutral pH so called soluble insulin, rapid or regular insulin. In order to prolong the duration of action of insulin, the preparation involves either complexing insulin with protein, protamine zinc, from which it is slowly released or modifying the particle size as in various insulin zinc suspension 
MATERIALS & METHODS

Materials
Experimental design Animals
Adult female albino rats weighing 130±15g were used. The animals were brought from laboratory animal breeding of National Organization for Drug Control and Research (NODCAR) Giza, Egypt. They were kept under strictly hygienic conditions. They were put on a standard basal diet and allowed free access to drinking water. The experimental protocols were approved by the NODCAR's Institutional Ethical Guidelines for Animal Care and Usage.
Induction of diabetes
All animals except 6 rats kept as a free control rats, were injected i.p with 70 mg/ kg B.wt of STZ dissolved in citrate buffer pH 4.5, freshly prepared and injected to rats within 5 minutes of preparation. After 7 days of injection, blood samples were withdrawn from retro-orbital vein of the STZ-treated rats as well as those of free control group. Blood samples were collected, left to coagulate and serum was harvested. STZ-treated rats which showed fasting serum glucose concentration more than 350 mg/dl were included in this study. respectively.
Statistical analysis:
One-way ANOVA with determination of least significant difference was applied to study the relationship between the different variables, using SPSS version 11.5, P<0.05 was considered significant.
RESULTS
Effect on blood glucose level:
In the light of observation recoded in this work, table.1 showed a significant decrease (P<0.05, 86%) in the level of blood glucose after one week of treatment against hyperglycemia induced by STZ, the hypoglycemic effect was pronounced in PC and PPC groups and to a lesser extend in SP group while those treated with Y & YA showed a lesser effect (P<0.05, 9% and 19% glucose reduction respectively). The data showed that the hyperglycemic state of rats injected with INSUGEAST preps in biphasic form, showed marked improvement that increase with duration (table1). In conform, the light microscopic examination of pancreas of 1 st group, observed no alteration in the island of Langerhans cells except some congestion in the surrounding blood vessels in group of rats treated by PPC (Fig P 4 ) . While, in PC treatment, they showing intact histological structure of island of langerhans cells (Fig P5) against the dramatic effect showed in STZ diabetic rats (Fig P 1,2,3 ). In contrast, rats treated with either regular form or yeast cells, the severity of hyperglycemia increase and potent activity of insulin for glucose reduction decreased to 30% with INSUGEAST preps and to 0% with yeast cells (table1). Also animals could not survive and mortality rate increase up to 60% during the last 2weeks of treatment (table 2).
Histopatholoical examination of the pancreas of these groups still showed atrophy in the cells of island and dilated ducts in addition to leucocytes inflammatory cells between them (Fig  P 6 ). On the other hand, groups of rats treated with ST, SP still showing some atrophy and depletion in the island of Langerhans cells. The effect on hepato-renal dysfunction:
Regarding the effect of i.p injection of STZ to rats in this work, the results showed significant elevation (P<0.05) in the activities of liver enzymes (AST, ALT) as well as ALP compared to that observed in free control group (table3 a&b ). Histopathological examination of rat liver injected with STZ showed marked cystic dilatation of the bile duct as well as periductal fibrosis, congestion in the central and portal veins (Fig L 2 ) . Diffuse kupffer cells proliferation with mononuclear leucocytes inflammatory cells infiltration was observed in between the hepatocytes (Fig L 3 ) , in respect to the normal structure observed in free control group (Fig L 1 ) . Contrary the STZ diabetic rats treated with INSUGEAST preps (biphasic form) showed significant improvement (P<0.05) of liver enzymes as well as in ALP (P<0.05) compared to that recorded in STZ treated group. Moreover, data showed that insulin standard induced decreases in liver enzymes in the STZ-diabetic rats similar to that induced by INSUGEAST preps (table 3) . Furthermore the histopathological study on the liver of these groups showed mild changes (congestion in the central vein and sinusiods (Fig L 4 ) and all histopathological changes noted in the untreated group were still present. On the other hand, rats treated with INSUGEAST preps in regular form showed significant elevation (P<0.05) of liver enzymes and ALP (table 3) and the histopathological changes were similar as in STZ diabetic group. In addition to focal necrosis (FigL 5 ) and fatty changes (FigL 6 ) were found between the hepatocytes.
The analysis of blood urea and serum Creat in STZ diabetic rats showed marked increase (P<0.05) in both levels during period of experiment.
In conform, the histopathological study of kidney removed from STZ diabetic rats showed congestion of the gloermular tuft of glomeruli with swelling in the lining endothelium (Fig K 2 ) , focal tubular degeneration and haemorrhages (Fig K 3 ) in the corticomedullary junction, in respect to the normal structure observed in free control group (Fig K 1 ) . Treatment of STZ-diabetic rats with biphasic INSUGEAST especially PC showed significant improvement in kidney function (P<0.05) in comparison to the improvement effect of ST (table  3) . The histopathological study showed mild changes (congestion in the cortical blood vessels (Fig K 4 ) but most the histopathological changes noted in the untreated group were still present. In contrast, impaired renal function were recorded in rats treated with INSUGEAST preps of rabid form (table  3) and the histopathological study of these groups still showed congestion of the glomerular tuft with swelling in the lining endothelium, focal tubular degeneration and hemorrhages in addition to focal suppurative embolus in the cortical portion (Fig K 5 ) and focal fibrosis in the corticomedullary junction (Fig K 6 ) .
Effect on hyperlipidemia:
The data analysis showed marked increase (P<0.05) in the levels of TG, T-Ch, and LDL-Ch accompanied with highly significant decrease in levels of HDL-Ch in STZ-diabetic rats. 
DISCUSSION
The aim of this study was to visualize the possible hypoglycemic effect of three INSUGEAST preps (PC, PPC & SP) in IDDM and comparing it with that induced by insulin standard (ST). The study extended to evaluate the difference in effect between aforementioned preps in three different forms of action (regular, inside recombinant yeast cells and biphasic forms) against the stability and severity of hyperglycemia. The data showed that the hyperglycemic state of rats injected with INSUGEAST preps in biphasic form, showed marked improvement that increase with duration.
In conform, the histopathological study of pancreas of these groups, observed no/little changes in island of Langerhans cells. In accordance with the study of Grossman et al.
[23] , they evident that insulin treatment by implants or islet transplantation promotes β-cell regeneration in the STZ-diabetic mouse model of β-cell regeneration, and does so in a time dependent manner with longer treatment periods associated with greater recovery. They also suggested that the overall degree control of glycemic control affects regeneration with better control accelerating recovery of β-cell mass and function. Previous studies have shown that STZ-induced diabetes in rats is associated with vascular oxidative stress and dysfunction [24] . Recent study revealed that vascular dysfunction and oxidative stress strictly depend on insulin deficiency and are probably not associated with systemic toxic side effects of STZ [25] . On other hand, groups of rats treated with ST, SP showing partial improvement in the state of hyperglycemia. In consistent with the histopathological study, ST and SP injection still showing some atrophy and depletion in the cells of island Langerhans. To interpret the latter observations it was mentioned that insulin therapy does not diminished ß-cells damage in neonatal STZ injected rats, but partial ß-recovery of islets of Langerhans was observed [26] . Insulin facilitates entry of glucose into muscle, adipose and several other tissues by facilitated of hexose transporters. GLUT4 are the major transporters are present in cytoplasmic vesicles. Binding of insulin to receptors on such cells leads rapidly to fusion of those vesicles with the plasma membrane and insertion of the glucose transporters, which used for glucose uptake in the plasma membrane [27] . In addition, Insulin stimulates the liver to store glucose in the form of glycogen. It activates the enzyme hexokinase, which phosphorylates glucose, trapping it within the cell. Coincidently, insulin acts to inhibit the activity of glucose-6-phosphatase. Insulin also activates several of the enzymes that are directly involved in glycogen synthesis, including phosphofructokinase and glycogen synthase [28] .
In contrast, the severity of hyperglycemia in rats treated with insulin either in regular form or in yeast cells was increased and the potent activity of insulin for glucose reduction was decreased. Also animals could not survive and mortality rate increased. These worst effects of insulin, might be due to that insulin action in regular form extend only for little hours of the day and so that rats in these groups subjected to hyperglycemia at the most hours of the day and behaved as poor control diabetes or insufficient short-acting insulin treatment. Concomitantly, the study of Ozlem et al. [29] observed that the levels of hyperglycemia were higher in the STZ + insulin group than those in the STZ-only group. Histopathology was similar in the STZ and STZ + insulin groups, and degeneration was observed in both groups, but immunohistochemistry revealed a more severe reduction in insulin-secreting cells in the STZ + insulin group than that in the STZ group. So this study showed that insufficient short-acting insulin treatment can increase the diabetogenic effect of STZ in rats. In addition, insulin inside recombinant yeast cells might undergo successive degradation inside the alkaline media of the animal intestine and these degradations might be responsible for the morbidity and mortality of these animals. Confirming the biochemical observations, histopatholoical examination of the pancreas of these groups still showed atrophy in the cells of island and dilated ducts in addition to leucocytes inflammatory cells between them.
The 2 nd target of this study was to compare the possible protective effect of the 3 forms of tested INSUGEAST preps against the hepato-renal dysfunction and hyperlipidemia response to STZ injection. The data in this study declared impairment in liver enzymes by STZ injection and this showed by increasing the levels of liver enzymes (AST, ALT) as well as ALP. Concomitantly, it was observed that injection of STZ to rats was followed by massive impairment in the liver function and ALP [1, 30] . The elevated levels of AST and ALT enzymes in STZ-diabetic rats are thought to be consisted with their greater need for gluconeogenic substrate and were attributed to induce synthesis of these enzymes [31] . Confirming the later biochemical observation, histopathological examination of rat liver injected with STZ showed obvious changes in liver structure. In agreement with the study of Ebrahim et al.
[1] , it was found that STZ injection showed marked dilatation of the central vein, vacuolization and ballooning with disorganization of hepatocytes. Contrary, treatment with the INSUGEAST preps (in biphasic form) showed marked improvement of liver enzymes as well as in ALP. Moreover, data showed that insulin standard induced decreases in liver enzymes in the STZ-diabetic rats similar to that induced by these preps. Insulin was reported by many investigators to improve the enzymatic alteration in liver tissue in STZ induced diabetes [32] . Mechanism of insulin action was through control the key enzymes of metabolism by phosphorylation or dephosphorylation of tyrosine residues. The insulin receptor is a tyrosine kinase, it functions as an enzyme that transfers phosphate groups from ATP to tyrosine residues on intracellular target proteins. Binding of insulin to the alpha subunits causes the beta subunits to phosphorylate themselves, thus activating the catalytic activity of the receptor. The activated receptor then phosphorylates a number of other intracellular proteins, in order to convert them to an active state. The resent study of Chen et al. [33] showed that the capture of phosphoproteins by 14-3-3 proteins mediates actions of insulin. Furthermore it was showed that insulin-treated diabetic animals showed greater silymarin-induced hepatoprotection against antitubercular drugs-induced liver injury, which was characterized by near normal levels of marker enzymes, an increase in total proteins and normal hepatic structure to normal value [34, 35] . In conform, the histopathological study on the liver of these groups showed mild improvement to the structural changes induced by STZ.
An additive worse effect in both liver enzymes and structure was recorded in rats treated with INSUGEAST preps in regular form. These are in consistent with the study of Ozlem et al.
[28] , they showed that insufficient short-acting insulin treatment can increase the diabetogenic effect of STZ in rats, histopathology was similar in the STZ and STZ + INS groups, degeneration was observed in both groups, and immunohistochemistry revealed a more severe reduction in insulinsecreting cells in the STZ + INS group than that in the STZ group.
Another principal focus in this work was studying the therapeutic use of INSUGEAST preps against the toxic effects induced by STZ injection on the biochemical and structural changes in the kidney of treated groups. The elevation of both blood urea and serum Creat in the present study evident the nephrotoxic effect induced by STZ injection. In consistent with studies of Sjoquist et al. [36] ; and Imaeda et al. [29] , they recorded impaired renal function after STZ injection. In addition the histopathological study of kidney removed from STZ diabetic rats showed marked changes in both glomeruli and tubules of kidney. Type1 diabetes is considered as one of the most precipitating factors of renal failure it start with gloemerular affection and end, in poor control and chronicity, with tubular affections [37] . Treatment of STZ-diabetic rats with biphasic INSUGEAST especially PC showed marked improvement in kidney function. Several investigators showed that insulin can prevent impaired kidney function in STZ diabetic rats
[1] and it can used to regain hypertrophied kidney to its normal weight [38] . Furthermore, STZinduced diabetes causes impairment in calcium/calmodulin-dependent contractile process of vas deferens, which is correctable partially following insulin therapy [39] . In addition to the biochemical analysis, mild improvement in kidney structure was observed by insulin preps. In contrast, worse effect in both kidney enzymes and structure was recorded in rats treated with INSUGEAST preps in regular form. These may be due to the insufficient short-acting insulin treatment, in the regular form, which can increase the diabetogenic effect of STZ in rats. Thus the resultant impairment hepato-renal function of these groups of regular form was secondary to/accompanied to the severity state of hyperglycemia.
The present investigation was extended to test the effect of i.p injection of STZ on lipid metabolism and the possible ameliorative effect of INSUGEAST preps.
The dyslipidemia of these groups showed positive correlation with the severity of hyperglycemia. Mountains of researches were done, and all of which pointing to marked elevation in all fraction of lipid except HDL-Ch which showed negative correlation with the severity of the diabetes [40, 41] . The hypolipidemic action of insulin was reports early by several investigators [ 42, 43] , in which insulin is the 1 st not the 2 nd drug in treatment of hyperlipidemia in IDDM. Insulin promotes synthesis of fatty acids in the liver. When the liver is saturated with glycogen, any additional glucose taken up by hepatocytes is shunted into pathways leading to synthesis of fatty acids, which are exported from the liver as lipoproteins. The lipoproteins are ripped apart in the circulation, providing free fatty acids for use in adipocytes, which use them to synthesize triglyceride. Insulin inhibits lipase in adipose tissue that hydrolyzes triglycerides to release fatty acids. Insulin also facilitates entry of glucose into adipocytes, and within those cells, glucose can be used to synthesize glycerol. This glycerol, along with the fatty acids delivered from the liver, is used to synthesize triglyceride within the adipocyte. By these mechanisms, insulin is involved in further accumulation of triglyceride in fat cells [44] . From a whole body perspective, insulin has a fat-sparing effect. Not only does it drive most cells to preferentially oxidize carbohydrates instead of fatty acids for energy, insulin indirectly stimulates accumulation of fat in adipose tissue.
In conclusion the INSUGEA preps in biphasic form had the more potent effect in management of STZinduced IDDM not only synergist the hypoglycemic action of standard insulin, but also prevent the occurrence of most common series complication of diabetes (hepato-renal impairment and dyslipidemia). These effects were pronounced in PC and PPC preps and to a lesser extend in SP prep. This may encourage to advice to use these preps in Egyptian markets. Also we need to pay more attention to verify from the amount of protamine zinc in the preps and use insulin the biphasic form. 
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